Search

Cap3G-TAR-F1
Authors
Summers, M.F., Brown, J.D.
Assembly
RNA (34-MER)
Entity
1. RNA (34-MER) (polymer, Thiol state: not present), 34 monomers, 11104.53 Da Detail

XGGGUCUCUC UUGUCGAGAG GCAAGGAACC CACU


Formula weight
11104.53 Da
Source organism
Human immunodeficiency virus 1
Exptl. method
solution NMR
Data set
assigned_chemical_shifts
Chem. Shift Complete
Sequence coverage: 97.1 %, Completeness: 54.0 %, Completeness (bb): 50.5 % Detail

Polymer type: polyribonucleotide

Total1H
All54.0 % (156 of 289)54.0 % (156 of 289)
Suger, PO450.5 % (100 of 198)50.5 % (100 of 198)
Nucleobase61.5 % (56 of 91)61.5 % (56 of 91)
Aromatic76.7 % (56 of 73)76.7 % (56 of 73)

1. entity 1

XGGGUCUCUC UUGUCGAGAG GCAAGGAACC CACU

Sample

Solvent system 100% D2O, Pressure 1 atm, Temperature 308 K, pH 7.4, Details 150 uM Fully protonated Cap3G-TAR-F1, 10 mM Deuterated KH2PO4, 100% D2O


#NameIsotope labelingTypeConcentration
1Cap3G-TAR-F1Fully protonated150 uM
2KH2PO4Deuterated10 mM

Release date
2020-04-06
Citation
Structural basis for transcriptional start site control of HIV-1 RNA fate
Brown, J.D., Kharytonchyk, S., Chaudry, I., Iyer, A.S., Carter, H., Becker, G., Desai, Y., Glang, L., Choi, S.H., Singh, K., Lopresti, M.W., Orellana, M., Rodriguez, T., Oboh, U., Hijji, J., Ghinger, F.G., Stewart, K., Francis, D., Edwards, B., Chen, P., Case, D.A., Telesnitsky, A., Summers, M.F.
Science (2020), 368, 413-417, PubMed 32327595 , DOI 10.1126/science.aaz7959 ,
Related entities 1. RNA (34-MER), : 1 entities Detail
Experiments performed 2 experiments Detail
nullKeywords HIV genome, Leader RNA, RNA, RNA genome, capped RNA, free cap, genome, nucleotides, start site exposed cap, viral, virus